Exploring Antibiotic Resistance Mechanisms in for Enhanced Therapeutic Approaches

Overview

Journal Front Microbiol

Specialty Microbiology

Date 2024 Feb 21

PMID 38380095

Authors

Thanh Quang Nguyen

Bo Eun Heo

Seunghyeon Jeon

Anwesha Ash

Heehyun Lee

Cheol Moon

Jichan Jang

Affiliations

Soon will be listed here.

Abstract

, a leading cause of severe lung infections in immunocompromised individuals, poses significant challenges for current therapeutic strategies due to resistance mechanisms. Therefore, understanding the intrinsic and acquired antibiotic resistance of is crucial for effective treatment. This review highlights the mechanisms employed by to sustain antibiotic resistance, encompassing not only conventional drugs but also newly discovered drug candidates. This comprehensive analysis aims to identify novel entities capable of overcoming the notorious resistance exhibited by , providing insights for the development of more effective therapeutic interventions.

Citing Articles

Fate of cultured populations when exposed to moxifloxacin.

Salina E, Martini B, Sorokin V, Mulyukin A Front Microbiol. 2024; 15:1494147.

PMID: 39669783 PMC: 11635960. DOI: 10.3389/fmicb.2024.1494147.

Trehalose polyphleates participate in fitness and pathogenesis.

Malmsheimer S, Daher W, Tasrini Y, Hamela C, Aguilera-Correa J, Chalut C mBio. 2024; 15(12):e0297024.

PMID: 39475242 PMC: 11633156. DOI: 10.1128/mbio.02970-24.

Phosphatidylserine liposomes induce a phagosome acidification-dependent and ROS-mediated intracellular killing of in human macrophages.

Olimpieri T, Poerio N, Ponsecchi G, Di Lallo G, DAndrea M, Fraziano M Front Cell Infect Microbiol. 2024; 14:1443719.

PMID: 39224705 PMC: 11366698. DOI: 10.3389/fcimb.2024.1443719.

The Many Lives of Auranofin: How an Old Anti-Rheumatic Agent May Become a Promising Antimicrobial Drug.

Coscione F, Zineddu S, Vitali V, Fondi M, Messori L, Perrin E Antibiotics (Basel). 2024; 13(7).

PMID: 39061334 PMC: 11274207. DOI: 10.3390/antibiotics13070652.

Efficacies of omadacycline + amikacin + imipenem and an all-oral regimen omadacycline + clofazimine + linezolid in a mouse model of lung disease.

Ignatius E, Rimal B, Panthi C, Belz D, Lippincott C, Deck D mSphere. 2024; 9(7):e0038124.

PMID: 38980071 PMC: 11288010. DOI: 10.1128/msphere.00381-24.

References

Greendyke R, Byrd T . Differential antibiotic susceptibility of Mycobacterium abscessus variants in biofilms and macrophages compared to that of planktonic bacteria. Antimicrob Agents Chemother. 2008; 52(6):2019-26. PMC: 2415760. DOI: 10.1128/AAC.00986-07. View

Christianson S, Grierson W, Kein D, Tyler A, Wolfe J, Sharma M . Time-to-Detection of Inducible Macrolide Resistance in Mycobacterium abscessus Subspecies and Its Association with the Erm(41) Sequevar. PLoS One. 2016; 11(8):e0158723. PMC: 4973996. DOI: 10.1371/journal.pone.0158723. View

Lan T, Ganapathy U, Sharma S, Ahn Y, Zimmerman M, Molodtsov V . Redesign of Rifamycin Antibiotics to Overcome ADP-Ribosylation-Mediated Resistance. Angew Chem Int Ed Engl. 2022; 61(45):e202211498. PMC: 9633546. DOI: 10.1002/anie.202211498. View

Gorzynski M, Week T, Jaramillo T, Dzalamidze E, Danelishvili L . Genetic Determinants Associated with the Intrinsic Resistance to Antibiotics. Microorganisms. 2021; 9(12). PMC: 8707978. DOI: 10.3390/microorganisms9122527. View

Moore M, FRERICHS J . An unusual acid-fast infection of the knee with subcutaneous, abscess-like lesions of the gluteal region; report of a case with a study of the organism, Mycobacterium abscessus, n. sp. J Invest Dermatol. 1953; 20(2):133-69. DOI: 10.1038/jid.1953.18. View

Moore J, Koulianos G, Hardy M, Misawa N, Millar B . Antimycobacterial activity of veterinary antibiotics (Apramycin and Framycetin) against : Implication for patients with cystic fibrosis. Int J Mycobacteriol. 2018; 7(3):265-267. DOI: 10.4103/ijmy.ijmy_73_18. View

Brennan P, Nikaido H . The envelope of mycobacteria. Annu Rev Biochem. 1995; 64:29-63. DOI: 10.1146/annurev.bi.64.070195.000333. View

Falkinham 3rd J . Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease. Emerg Infect Dis. 2011; 17(3):419-24. PMC: 3166028. DOI: 10.3201/eid1703.101510. View

Watkins R, Deresinski S . Omadacycline: A Novel Tetracycline Derivative With Oral and Intravenous Formulations. Clin Infect Dis. 2019; 69(5):890-896. DOI: 10.1093/cid/ciz242. View

10.

Tsai S, Lai H, Hu S . Subinhibitory Doses of Aminoglycoside Antibiotics Induce Changes in the Phenotype of Mycobacterium abscessus. Antimicrob Agents Chemother. 2015; 59(10):6161-9. PMC: 4576046. DOI: 10.1128/AAC.01132-15. View

11.

Ung K, Alsarraf H, Olieric V, Kremer L, Blaise M . Crystal structure of the aminoglycosides N-acetyltransferase Eis2 from Mycobacterium abscessus. FEBS J. 2019; 286(21):4342-4355. DOI: 10.1111/febs.14975. View

12.

Wassilew N, Hoffmann H, Andrejak C, Lange C . Pulmonary Disease Caused by Non-Tuberculous Mycobacteria. Respiration. 2016; 91(5):386-402. DOI: 10.1159/000445906. View

13.

Wu W, He S, Li A, Guo Q, Tan Z, Liu S . A Novel Leucyl-tRNA Synthetase Inhibitor, MRX-6038, Expresses Anti-Mycobacterium abscessus Activity and . Antimicrob Agents Chemother. 2022; 66(9):e0060122. PMC: 9487484. DOI: 10.1128/aac.00601-22. View

14.

Ishikawa M, Garcia-Mateo N, cusak A, Lopez-Hernandez I, Fernandez-Martinez M, Muller M . Lower ototoxicity and absence of hidden hearing loss point to gentamicin C1a and apramycin as promising antibiotics for clinical use. Sci Rep. 2019; 9(1):2410. PMC: 6382871. DOI: 10.1038/s41598-019-38634-3. View

15.

Harada T, Akiyama Y, Kurashima A, Nagai H, Tsuyuguchi K, Fujii T . Clinical and microbiological differences between Mycobacterium abscessus and Mycobacterium massiliense lung diseases. J Clin Microbiol. 2012; 50(11):3556-61. PMC: 3486228. DOI: 10.1128/JCM.01175-12. View

16.

Matt T, Ng C, Lang K, Sha S, Akbergenov R, Shcherbakov D . Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin. Proc Natl Acad Sci U S A. 2012; 109(27):10984-9. PMC: 3390888. DOI: 10.1073/pnas.1204073109. View

17.

Nguyen L, Thompson C . Foundations of antibiotic resistance in bacterial physiology: the mycobacterial paradigm. Trends Microbiol. 2006; 14(7):304-12. DOI: 10.1016/j.tim.2006.05.005. View

18.

Brown-Elliott B, Rubio A, Wallace Jr R . Susceptibility Testing of a Novel Benzimidazole, SPR719, against Nontuberculous Mycobacteria. Antimicrob Agents Chemother. 2018; 62(11). PMC: 6201134. DOI: 10.1128/AAC.01503-18. View

19.

Gutierrez A, Richard M, Roquet-Baneres F, Viljoen A, Kremer L . The TetR Family Transcription Factor MAB_2299c Regulates the Expression of Two Distinct MmpS-MmpL Efflux Pumps Involved in Cross-Resistance to Clofazimine and Bedaquiline in Mycobacterium abscessus. Antimicrob Agents Chemother. 2019; 63(10). PMC: 6761555. DOI: 10.1128/AAC.01000-19. View

20.

Hanh B, Park J, Kim T, Kim J, Yang C, Jang K . Rifamycin O, An Alternative Anti- Agent. Molecules. 2020; 25(7). PMC: 7181020. DOI: 10.3390/molecules25071597. View